Patents by Inventor Junro Kuromitsu

Junro Kuromitsu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of testing anticancer agent-sensitivity of tumor cells
    Patent number: 7445892
    Abstract: Susceptibility of a tumor cell to an anticancer agent is tested by measuring an expression level or levels of a gene or genes selected from the group consisting of the genes listed in Tables 3 and 4 in a tumor cell collected from a cancer patient treated with an anticancer agent (E7070 and related compounds thereof), or causing the anticancer agent to act on a tumor cell collected from a cancer patient and measuring an expression level or levels of a gene or genes selected from the group consisting of the genes listed in Tables 3 and 4 in the tumor cell, and determining that the tumor cell is susceptible to the anticancer agent when the expression level or levels of the gene or genes listed in Table 3 increase, or the expression level or levels of the gene or genes listed in Table 4 decrease.
    Type: Grant
    Filed: November 26, 2001
    Date of Patent: November 4, 2008
    Assignee: Eisai Co., Ltd.
    Inventors: Takashi Owa, Akira Yokoi, Junro Kuromitsu, Takatoshi Kawai, Hiroyuki Kato, Takeshi Nagasu
  • Methods for identifying GPR83 agonists and GPR83 antagonists capable of modulating regulatory T cell function
    Publication number: 20070122845
    Abstract: The present invention provides methods for identifying a GPR83 agonist capable of stimulating a regulatory T cell function and methods for identifying a GPR83 antagonist capable of suppressing a regulatory T cell function.
    Type: Application
    Filed: September 15, 2006
    Publication date: May 31, 2007
    Applicant: Eisai R&D Management Co., Ltd.
    Inventors: Tetsu Kawano, Junro Kuromitsu, Akiko Hamaguchi, Keiko Yamaguchi, Takashi Seiki, Kazuma Takase
  • Method of testing anticancer agent-sensitivity of tumor cells
    Publication number: 20040115664
    Abstract: Susceptibility of a tumor cell to an anticancer agent is tested by measuring an expression level or levels of a gene or genes selected from the group consisting of the genes listed in Tables 3 and 4 in a tumor cell collected from a cancer patient treated with an anticancer agent (E7070 and related compounds thereof), or causing the anticancer agent to act on a tumor cell collected from a cancer patient and measuring an expression level or levels of a gene or genes selected from the group consisting of the genes listed in Tables 3 and 4 in the tumor cell, and determining that the tumor cell is susceptible to the anticancer agent when the expression level or levels of the gene or genes listed in Table 3 increase, or the expression level or levels of the gene or genes listed in Table 4 decrease.
    Type: Application
    Filed: May 23, 2003
    Publication date: June 17, 2004
    Inventors: Takashi Owa, Akira Yokoi, Junro Kuromitsu, Takatoshi Kawai, Hiroyuki Kato, Takeshi Nagasu